Growth inhibitory effects of PC‑NSAIDs on human breast cancer subtypes in cell culture

  • Authors:
    • Shelley Burge
    • Lenard M. Lichtenberger
  • View Affiliations

  • Published online on: October 2, 2019     https://doi.org/10.3892/ol.2019.10951
  • Pages: 6243-6248
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The potential role of non‑steroidal anti‑inflammatory drug (NSAID) therapy in the prevention and treatment of cancer has generated considerable research interest. Phosphatidylcholine (PC)‑associated NSAIDs decrease the gastrointestinal side effects of NSAID therapy, and may be more effective than traditional NSAIDs in limiting tumor growth. In the present study, human cells representing three major breast cancer subtypes were cultured with aspirin, indomethacin and PC‑associated forms of each drug, with PC alone as a control. All tested drugs decreased the tumor cell number after 8 days of culture, with PC‑NSAIDs having the greatest inhibitory effect, and NSAIDs alone, particularly aspirin, having the least effect. PC alone was effective in limiting the proliferation of all cell lines, suggesting that the two components of PC‑NSAIDs have an additive effect. The ELISA results did not support a strong role for inhibition of cyclooxygenase enzymes in the decrease in cancer cell proliferation, which may account for the limited effectiveness of aspirin alone. PC‑NSAIDs, particularly indomethacin‑PC, are attractive candidate drugs in the prevention and treatment of different types of breast cancer, including triple negative breast cancer.

Related Articles

Journal Cover

December 2019
Volume 18 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Burge, S., & Burge, S. (2019). Growth inhibitory effects of PC‑NSAIDs on human breast cancer subtypes in cell culture. Oncology Letters, 18, 6243-6248. https://doi.org/10.3892/ol.2019.10951
MLA
Burge, S., Lichtenberger, L. M."Growth inhibitory effects of PC‑NSAIDs on human breast cancer subtypes in cell culture". Oncology Letters 18.6 (2019): 6243-6248.
Chicago
Burge, S., Lichtenberger, L. M."Growth inhibitory effects of PC‑NSAIDs on human breast cancer subtypes in cell culture". Oncology Letters 18, no. 6 (2019): 6243-6248. https://doi.org/10.3892/ol.2019.10951